The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
The SNG results today just show people waiting on Avacta to pop what is coming. All that money will flow through here when results announced. What a year 2020 has been for multibaggers. Lets keep them coming. looking forward to Avacta getting its day very soon.
Fri, 17th Jul 2020 07:00
RNS Number : 2787T
Escape Hunt PLC
17 July 2020
17 July 2020
Escape Hunt plc (AIM: ESC)
("Escape Hunt" or the "Company")
Management incentive scheme
Escape Hunt, a leading operator of escape rooms in the fast-growing experiential leisure sector, announces that a new share incentive scheme has now been established for its senior executives as was highlighted in the Company's circular to shareholders in relation to the recent Placing and Open Offer, Subscription, and issue of Convertible Loan Notes, dated 15 June 2020 (the "Circular").
The rules of the scheme are in line with the outline provided in the Circular with the exception of the introduction of an additional performance hurdle required to be able to exercise 100 per cent. of the options and a correction in the maximum number of options to be issued to each of Richard Harpham, the Group Chief Executive Officer, and Graham Bird, the Group Chief Financial Officer, to equate to the agreed salary multiple, which remains as set out in the Circular. A summary of the key features of the scheme is set out below:
· Each member of the senior leadership team has been awarded options with an aggregate exercise price equal to two times their current annual salary.
· The exercise price of the options is 7.5 pence, which is the same as the issue price in the recent Fundraising.
· The options will vest in three equal tranches on the first, second and third anniversaries of the award.
· The options are subject to a performance condition based on the Company's share price. This will be tested on each vesting date and again between the third and fourth anniversaries of the awards.
· If the Company's share price at testing is 11.25 pence (being 1.5 times the issue price), one third of the vested options will be exercisable.
· If the Company's share price at testing is 18.75 pence (being 2.5 times the issue price), 90 per cent of the vested options will be exercisable.
· If the Company's share price at testing is 25 pence (being 3.33 times the issue price), 100% of the vested options will be exercisable.
· The proportion of vested options exercisable for share prices between 11.25 pence and 18.75 pence will scale proportionately from one-third to 90 per cent. Similarly, the proportion of options exercisable for share prices between 18.75 pence and 25 pence will scale proportionately from 90 per cent. to 100 per cent.
· The options will all vest in the case of an offer for the Company being completed. If the offer price per share is 7.5 pence, no options will be exercisable. If the offer price per share is 18.75 pence, 100 per cent. of the options will be exercisable. The proportion of options exercisable between offer prices of 7.5 pence and 18.75 pence per share will scale proportionately from nil to 100 per cent.
· If not exercised, the options will expire on the fif
It's the old cliche but this 'really is one you do not want to be out of over the weekend'. I expect this to build into Friday and drop a little on Monday with no news, then rinse and repeat until we get the news.
EUA was always a great day trading share and you could nibble away and build your shares for free but my advice now is to just sit on your hands. I have been caught twice here trying to grab free shares. News could drop anytime & you get frozen out.
Just my advice. GL everyone...EUA has been a wild ride. Looking forward to the big payday :)
Bloomberg
California’s surge in infections continued, with the largest U.S. state reporting near-record increases in cases and deaths, while Los Angeles had record hospitalizations. And adding to concerns, data showed that the virus also appears to be spreading in Asia.
We need Avacta/Cytiva more than ever...we are going to be dealing with test track and trace for the next 18mths at the very least.
The other reason I love Avacta is their ability to asct quickly in pinning down the protein. One of the big questions now is what happens if ithe virus mutates? Companies like Avacta who manages to nail it in 3 or 4 weeks will be invaluable.
Don't mind the wait and low prices here. News is imminent and we will be in huge demand.
GL all
Avacta BOD have played the whole situation for the last 6 months perfectly from their point of view and I personally am fine with it. As a company they have managed to permanently raise the SP and raise all the funds needed to push their Cancer projects through.
It's simply a change of mindset required and people should stop focusing on the quick profit from the cCovid tests (which I am sure we will hear any day now). Instead, focus on the unbelievable Cancer pipeline and take what happens over Covid tests and a bonus. Sir Al has made it clear, the real value for Avacta will come next year with the cancer treatment results. Then everyone will be talking about £5, £10 +
This company is doing everything right. We are kept updated when news is available and I think the BOD have proven themselves very adept at doing what is best for Avacta and in return, we, the shareholder are being rewarded.
If you bought in high and got spiked then simply bottom drawer this share and come back next summer to a share that will be many multiples of this price.
Directors Dealings 12th June 2020
Date - Director name - position Deal type - No. shares dealt - Price - Value of trade - Director's shares remaining
12 Jun 2020 Rose, Richard Stanley Chairman of the Board Purchase 1,333,334.00 £0.075 £100,000.05 1,387,000.00
12 Jun 2020 Harpham, Richard CEO Purchase 533,334.00 £0.075 £40,000.05 557,400.00
12 Jun 2020 Bird, Graham John CFO Purchase 1,333,334.00 £0.075 £100,000.05 1,333,334.00
12 Jun 2020 Bach, Karen Non-Executive Director Purchase 133,334.00 £0.075 £10,000.05 142,400.00
https://www.hl.co.uk/shares/shares-search-results/e/escape-hunt-plc-ord-1.25p/director-deals
One of Tripadvisors top rated UK attraction with over a thousand 5* reviews for it individual locations
Just raised £4m+ for investment & expansion.
11 July 2020 sees Escape Hunt open its doors in England again, Scotland to follow in a few weeks when permission grated.
Company welcomes the Treasury's reduction of VAT to 5 per cent from 20 per cent in the hospitality and leisure sectors.
All furloughed staff going to get £1000
Escape Hunt plans to open a further 5 to 6 UK owner operated sites within a year of the fundraising, as the company expects property market conditions to offer highly attractive opportunities when the time comes.
PLUS - they are going to start operating franchises in both USA & Canada.
Current price is 7.5p...seriously undervalued. I personally believe this company can continue to build on the numbers it was generating prior to lockdown and fully expect this share price to multibag many times.
All my own opinion & do your own research but the future looks very bright here.
GL all
....and just wanted to say to anyone new to this share it can be volatile. The MMs were masters of bouncing it. I saw people ride this share every day and made huge sums of money but in the end some got caught out when the share was frozen. So in the coming day and weeks expect this to be day traded. You can risk taking part in those games if that's your thing or just sit back and wait for true value to show. Buying in here under 20p you will be a happy bunny in the weeks/months ahead.
Good luck to all
People joining need to realise that EUA is completely undervalued at the moment. Even if we went ahead and mined ourselves we would be pulling in 2-3x as much profit per year as someone like Sylvania Platinum who are currently trading at 43p. As far as I'm concearned EUA are sitting on the biggest Palladium play globally so I very much doubt we will get to mine ourselves. One of the majors will buy us for a considerable sum of money.
I think the EUA board have been very smart as always, knowing that the SP would be driven up by market sentiment. This will probably get to 20p+ then news on flanks will be added to see a major re-rate.
https://www.google.com/search?tbm=fin&sxsrf=ALeKk02sSIvXnaCT2AKU-tCIkCIXROu25g:1594381580167&q=LON:+SLP#scso=_IFUIX4qRHrHF8gLAjJ2QBw1:0
Expecting a nice rise today into the weekend. FOMO will be real here and we all know what's going to happen when they announce the second license.
I believe that as usual EUA BOD are playing it masterfully and will wait till sp grows and tops out then add in the other 40m ounces to boost it again.
Anyway...more than happy to sit back and let this ride. They long wait all through winter is coming good now. Here's to a sale of the full project and a massive payday to us all.
Good AGM & then a recap by Brad.
I am very much looking forward to the next 12months here. This mine is an absolute no brainer to me. Funding will be coming and this will multibag many times over.
I feel very fortunate to be in here at these prices. I personally know people who were in here are 8p and they became concerned how things were handled in 2019 with regards to dilution and the need to raise $1.6bil at that time. KP is a completely different animal now. The focus now on the smaller DX project which is super fast and cheap time to production with an annual free cashflow projection of $95m/yr is the secret sauce and the no.1 reason that this project will definitely find it's funding.
This may take time to build up to its true value but to be able to buy now at prices of 1p it is a gift, extremely undervalued.
I'm mobile at the moment but I will type up some notes from the meeting when I get a chance.
Kore Potash plc, the potash development company whose flagship asset is the 97%-owned Sintoukola Potash Project, is pleased to advise that the Company will provide remote 'listen-in' access to the Company's Annual General Meeting ("AGM") via a dial-in facility.
As previously announced the AGM will be held at 11:00 (UK) on 26 June 2020 at Suite 31, Second Floor, 107 Cheapside, London EC2V 6DN, but due to COVID-19 restrictions, in person attendance is not possible.
In order to access the AGM remotely please use one of the below facilities:
UK: +44 33 0606 1122
South Africa: +80 006 4593
Australia: +61 2 8311 1558
Room number:167133
Participant PIN: 8019
For a full list of international dial in numbers please see here: https://public.speakservecloud.com/dial-in-numbers/ee9d2673-7e37-4058-889c-e4a9ff59f4a7
Following the formal business of the meeting Brad Sampson, CEO, will give a short presentation, the presentation slides for which will be available on the Company's website, along with copies of the other meeting materials at www.korepotash.com
Yep, people selling now are ones we can do without anyway. Short term holders that were looking for a quick profit from Bellusura FDA approval.
Selling this share for 10 or 11p is complete madness but each to their own, we are all on our own paths. Salarius & Guident are both worth many multiples of the current share price each! Their time has come.
I just hope it keep going down as I have some other shares to sell tomorrow and will be adding profits here. 10p would be perfect please.